Pascale David‐Pierson

494 total citations
7 papers, 154 citations indexed

About

Pascale David‐Pierson is a scholar working on Pharmacology, Physiology and Computational Theory and Mathematics. According to data from OpenAlex, Pascale David‐Pierson has authored 7 papers receiving a total of 154 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 3 papers in Physiology and 2 papers in Computational Theory and Mathematics. Recurrent topics in Pascale David‐Pierson's work include Cholinesterase and Neurodegenerative Diseases (3 papers), Alzheimer's disease research and treatments (3 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Pascale David‐Pierson is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (3 papers), Alzheimer's disease research and treatments (3 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Pascale David‐Pierson collaborates with scholars based in Switzerland, Sweden and Germany. Pascale David‐Pierson's co-authors include Thierry Lavé, Laurence Ozmen, Helmut Jacobsen, Neil Parrott, Anders Kristoffersson, Elisabet I. Nielsen, Lena E. Friberg, Olaf Kuhlmann, Eric Kitas and Guido Galley and has published in prestigious journals such as Pharmaceutical Research, Drug Discovery Today and European Journal of Pharmaceutics and Biopharmaceutics.

In The Last Decade

Pascale David‐Pierson

7 papers receiving 150 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascale David‐Pierson Switzerland 7 66 37 35 28 25 7 154
Gefei He China 8 45 0.7× 29 0.8× 51 1.5× 7 0.3× 28 1.1× 22 278
Chieko Ikeda Japan 6 46 0.7× 23 0.6× 25 0.7× 9 0.3× 11 0.4× 9 133
Scott Reuschel United States 10 30 0.5× 20 0.5× 107 3.1× 12 0.4× 16 0.6× 16 245
Yangang Zhou China 11 85 1.3× 93 2.5× 71 2.0× 8 0.3× 54 2.2× 27 287
Ursula Gutteck Switzerland 6 33 0.5× 6 0.2× 78 2.2× 8 0.3× 40 1.6× 9 271
Hemant Arya India 9 28 0.4× 10 0.3× 91 2.6× 32 1.1× 9 0.4× 19 249
Jingye Zhou United States 9 81 1.2× 58 1.6× 81 2.3× 208 7.4× 23 0.9× 15 343
Marwa Hassan Shukr Egypt 13 13 0.2× 23 0.6× 63 1.8× 31 1.1× 5 0.2× 17 353

Countries citing papers authored by Pascale David‐Pierson

Since Specialization
Citations

This map shows the geographic impact of Pascale David‐Pierson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascale David‐Pierson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascale David‐Pierson more than expected).

Fields of papers citing papers by Pascale David‐Pierson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascale David‐Pierson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascale David‐Pierson. The network helps show where Pascale David‐Pierson may publish in the future.

Co-authorship network of co-authors of Pascale David‐Pierson

This figure shows the co-authorship network connecting the top 25 collaborators of Pascale David‐Pierson. A scholar is included among the top collaborators of Pascale David‐Pierson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascale David‐Pierson. Pascale David‐Pierson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Bissantz, Caterina, Claudia Zampaloni, Pascale David‐Pierson, et al.. (2024). Translational PK/PD for the Development of Novel Antibiotics—A Drug Developer’s Perspective. Antibiotics. 13(1). 72–72. 7 indexed citations
2.
Dudal, Sherri, Caterina Bissantz, Antonello Caruso, et al.. (2022). Translating pharmacology models effectively to predict therapeutic benefit. Drug Discovery Today. 27(6). 1604–1621. 8 indexed citations
3.
Kristoffersson, Anders, Pascale David‐Pierson, Neil Parrott, et al.. (2016). Simulation-Based Evaluation of PK/PD Indices for Meropenem Across Patient Groups and Experimental Designs. Pharmaceutical Research. 33(5). 1115–1125. 50 indexed citations
4.
Lübbers, Thomas, Alexander Flohr, Synèse Jolidon, et al.. (2011). Aminothiazoles as γ-secretase modulators. Bioorganic & Medicinal Chemistry Letters. 21(21). 6554–6558. 14 indexed citations
5.
Kitas, Eric, Guido Galley, Roland Jakob‐Roetne, et al.. (2007). Substituted 2-oxo-azepane derivatives are potent, orally active γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(1). 304–308. 17 indexed citations
6.
Peters, Jens‐Uwe, Guido Galley, Helmut Jacobsen, et al.. (2007). Novel orally active, dibenzazepinone-based γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(21). 5918–5923. 31 indexed citations
7.
Blanchard, Nadège, Eliane Alexandre, Frédéric Delobel, et al.. (2006). Cryopreserved human hepatocytes in suspension are a convenient high throughput tool for the prediction of metabolic clearance. European Journal of Pharmaceutics and Biopharmaceutics. 63(3). 347–355. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026